Avalon GloboCare (NASDAQ:CHGA – Get Free Report) and Kinaxis (OTCMKTS:KXSCF – Get Free Report) are both technology companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability.
Earnings and Valuation
This table compares Avalon GloboCare and Kinaxis”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avalon GloboCare | $1.26 million | 0.69 | -$18.26 million | ($13.80) | -0.06 |
| Kinaxis | $548.03 million | 7.49 | $70.70 million | $3.20 | 47.40 |
Kinaxis has higher revenue and earnings than Avalon GloboCare. Avalon GloboCare is trading at a lower price-to-earnings ratio than Kinaxis, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
1.4% of Avalon GloboCare shares are held by institutional investors. 16.8% of Avalon GloboCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Avalon GloboCare and Kinaxis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avalon GloboCare | N/A | N/A | -53.69% |
| Kinaxis | 14.35% | 22.31% | 12.48% |
Analyst Ratings
This is a breakdown of recent ratings for Avalon GloboCare and Kinaxis, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avalon GloboCare | 1 | 0 | 0 | 0 | 1.00 |
| Kinaxis | 0 | 0 | 4 | 0 | 3.00 |
Summary
Kinaxis beats Avalon GloboCare on 10 of the 12 factors compared between the two stocks.
About Avalon GloboCare
Avalon GloboCare Corp. is a biotechnology company historically focused on developing cell-based technologies, regenerative medicine applications and precision-medicine solutions. Its work has included research and development involving cellular therapies, immunotherapy and other platforms intended to support the treatment of serious diseases. The company’s reported activities have included the development of CAR-T and other cell-therapy approaches, exosome-related technologies, and diagnostic and biobanking services.
About Kinaxis
Kinaxis Inc. is a Canadian software company that develops cloud-based supply chain planning and management solutions. Its platform, Kinaxis Maestro, helps organizations coordinate planning across their supply chains and respond to changes in demand, supply and operations. Maestro supports activities such as demand and supply planning, inventory management, scenario analysis and sales and operations planning. The company also provides implementation, training and support services to help customers use its software.
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.
